Harrison.ai
Series C in 2025
Harrison.ai is a healthcare-focused AI company founded in 2018. Headquartered in Barongarook, Victoria, Australia, it uses deep learning to enhance IVF success rates and improve patient outcomes. The company empowers clinicians with customized AI tools that integrate into existing workflows.
Owlstone Medical
Series E in 2025
Owlstone Medical develops and commercializes breathalyzers for clinical diagnostics and precision medicine. Its products detect volatile organic compounds in breath samples to diagnose diseases like lung cancer, asthma, and tuberculosis. The company has strategic collaborations with pharmaceutical companies and is based in Cambridge, UK.
Fleet Space Technologies
Series D in 2024
Fleet Space Technologies operates a constellation of commercial micro-satellites, offering enhanced mineral exploration services globally. They have pioneered the world's first 3D printed all-metal patch antenna for space, significantly improving throughput efficiency.
Notpla develops sustainable packaging solutions derived from seaweed and plants. Its product range includes a coating for takeaway boxes, flexible films, paper made from seaweed pulp, and rigid plastic alternatives, all designed to be biodegradable and reduce plastic waste.
Founded in 2017, ZeroAvia develops zero-emission aircraft propulsion systems designed to eliminate aviation emissions while maintaining operational efficiency. The company focuses on scalable hydrogen-electric technologies that can retrofit existing aircraft and support sustainable aviation.
Medal
Venture Round in 2024
Medal is an online platform designed for gamers to create, watch, share, and analyze gaming highlights. The platform allows users to capture key moments from their gameplay using various recording methods, which can then be shared with others. This functionality enables gamers to showcase their skills and enhance their overall gaming experience by easily sharing digital clips and highlights from live streams.
Holoclara
Series A in 2024
Holoclara is an immunotherapy company focused on providing innovative solutions for individuals suffering from autoimmune disorders. The company specializes in delivering nematode-derived molecules known for their therapeutic properties. By identifying and developing these molecules from various worm species, Holoclara aims to create safe, orally available therapeutics that can improve the quality of life for patients. Through its targeted approach, Holoclara seeks to bring relief and promote overall health and well-being for those affected by autoimmune conditions.
Voyage Foods
Series A in 2024
Voyage Foods develops sustainable alternatives to popular foods. Using natural ingredients and proprietary technology, they create products like nut-free spreads, cocoa-free chocolate, and bean-free coffee that maintain original taste and nutrition without environmental compromise.
Fano Labs is an artificial intelligence company based in Shatin, Hong Kong, specializing in speech recognition and natural language processing technologies. Founded in 2015, the company focuses on developing solutions that enable the processing and analysis of various Chinese dialects, particularly Cantonese, as well as other Southeast Asian languages. Fano Labs serves a diverse range of sectors, including customer service, compliance, and operational efficiency for enterprises such as global banks, government agencies, and telecom companies. Their advanced AI technologies enhance management capabilities and service quality by accurately identifying compliance risks and analyzing customer sentiment. By providing valuable business intelligence, Fano Labs helps organizations reduce costs and uncover sales opportunities, ultimately driving revenue growth.
Cauldron Ferm
Series A in 2024
Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities faster and with a lower cost of goods than any traditional production method.
Founded in 2018, Xampla develops plant-based materials derived from pea protein to replace microplastics. Its product range includes microcapsules for homecare and personal care products, films, coatings, and single-use plastics for packaging applications.
MioTech
Venture Round in 2024
MioTech Information Technology (Shanghai) Co., Limited is an artificial intelligence platform based in Shanghai, China, with additional offices in Hong Kong. Founded in 2016, the company specializes in developing software solutions for investment managers, enabling them to navigate complex data and enhance client service. MioTech's platform integrates and analyzes diverse data sources to streamline the investment process, offering a data-driven experience. Additionally, the company focuses on sustainability and environmental, social, and corporate governance (ESG) data, providing financial institutions, enterprises, and governments with tools to monitor and manage sustainability metrics in real time. MioTech's innovative approach is supported by notable investors, including Horizons Ventures and ZhenFund.
CellVoyant
Seed Round in 2024
CellVoyant Technologies Limited is an innovative biotechnology company founded in 2021, focused on developing advanced stem cell-based therapies to address chronic diseases. The company employs an AI-first approach, utilizing live cell imaging technology to predict and optimize stem cell differentiation, which allows for the scalable and precise manufacturing of any human cell and tissue. CellVoyant's technology is rooted in pioneering research from the Carazo Salas lab at the University of Bristol, merging expertise in cell biology, computer vision, engineering, and machine learning. Led by Founder and CEO Rafael Carazo, the company aims to translate cutting-edge scientific advancements into real-world applications, addressing critical healthcare challenges. With a commitment to transforming the biotechnology landscape, CellVoyant is positioned to deliver effective, life-changing therapies to patients globally.
Perfect Day
Series E in 2024
Perfect Day develops animal-free dairy proteins and dairy substitutes using fermentation to produce proteins that are nutritionally identical to cow’s milk. The company makes products including milk, cheese, yogurt, ice cream, and milk proteins without using animals. Its fermentation process uses yeast to convert plant-based sugars into dairy proteins, enabling products with the same taste, texture, and nutrition as traditional dairy while avoiding animal welfare concerns and reducing environmental impact. Founded in 2014 and headquartered in Emeryville, California, Perfect Day focuses on sustainable, vegan dairy alternatives that aim to appeal to both consumers and manufacturers seeking dairy-like ingredients without conventional dairy farming.
Kimia Therapeutics
Series A in 2023
KimiaTherapeutics is a drug discovery business that uses high throughput precision chemistry in conjunction with genome editing and machine learning to uncover druggable sites at crucial nodes of intervention in human disease.
Evolv AI
Venture Round in 2023
Evolv AI is a developer of an artificial intelligence-driven optimization and personalization platform that aims to enhance digital experiences for customers. The company focuses on enabling digital leaders and content creators to engage customers effectively across various digital channels. Its proprietary platform employs a unique methodology to automatically discover and personalize user journeys by adapting to live user behavior. By defining experimentation strategies and generating a continuous stream of innovative ideas, Evolv AI helps organizations progressively improve their digital optimization efforts. This allows businesses to learn from each user interaction and refine their approaches, ultimately driving better customer engagement and conversion rates.
Promise Robotics
Series A in 2023
Promise Robotics empowers the construction industry by integrating industrial robotics and AI for affordable, sustainable building production. They offer ready-to-use robotic systems alongside SaaS Production Management Services, specializing in NetZero-ready timber buildings.
erthos is a producer of biodegradable packaging materials intended to replace traditional polystyrene and polypropylene inputs.
BioLoomics
Seed Round in 2023
BioLoomics is a biotechnology company that specializes in improving drug discovery and delivery. Founded in 2019, it offers drug screening services using biosensors to analyze drug action and toxicity in live cells. The company also develops tools for enhancing drug discovery efficiency and engineers proteins and cells for drug effect sensing with imaging technology.
Founded in 2017, ZeroAvia develops zero-emission aircraft propulsion systems designed to eliminate aviation emissions while maintaining operational efficiency. The company focuses on scalable hydrogen-electric technologies that can retrofit existing aircraft and support sustainable aviation.
ALVA is a manufacturer of electric bikes designed for urban commuting, focusing on performance, efficiency, and environmental sustainability. Assembled in Indonesia, ALVA's bikes prioritize motor efficiency and offer impressive torque and top speeds on a single charge. The company's products feature integrated intelligence that enhances rider security, personalization, and control, ensuring a superior riding experience. With a commitment to zero-emissions technology, ALVA aims to facilitate a transition to electric mobility while helping customers reduce riding costs.
Chemify specializes in developing a chemical digitization platform designed to facilitate drug and materials discovery as well as chemical synthesis. The company's innovative approach involves using automated synthetic hardware combined with digital XDL code to convert code into molecules on demand. This system is modular, universal, scalable, and teachable, making it highly versatile for various applications in chemical and material research. Chemify's software includes a unique chemical programming language and natural language recognition capabilities that translate synthetic procedures efficiently. Additionally, the platform features a comprehensive ontology that provides detailed insights into reaction conditions and flags potential issues, offering scientists real-time telemetry of reactions.
Cortical Labs
Seed Round in 2023
Cortical Labs is a pioneering biological computing startup that aims to transform traditional computing by integrating living neurons into chips. Its innovative biOS creates an interactive reality that transmits data through electrical signals, allowing neuronal activity to influence actions within this environment. This dynamic process enables the neurons to adapt in response to perceived outcomes, enhancing their efficiency and effectiveness. By harnessing the unique capabilities of human neurons, which have evolved over billions of years, Cortical Labs' technology offers a new generation of biological computer chips that provide fluid intelligence and energy efficiency. This advancement opens new possibilities for various sectors, including digital spaces, robotics, science, and personal care, facilitating the development of advanced autonomous systems for future applications.
Cauldron Ferm
Seed Round in 2023
Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities faster and with a lower cost of goods than any traditional production method.
Matchday
Seed Round in 2023
Matchday is a gaming platform tailored for football enthusiasts, offering a unique experience where users can collect and trade digital cards within a marketplace. By merging video games, sports, and Web3 technology, Matchday creates an engaging ecosystem for casual football games. The platform empowers users with true ownership of the cards and digital items they acquire, allowing them to build their dream teams and participate in gameplay seamlessly. Through this innovative approach, Matchday caters to the interests of football fans while promoting an interactive and dynamic gaming environment.
Doctorly is a health tech company that provides a cloud-based practice management platform for doctors to run their entire practice in one system. The platform includes digital booking, video conferencing, electronic health records, and patient health analysis, and offers a connected patient app along with an integration platform to natively connect tools and workflows within the healthcare ecosystem. The goal is to save doctors time, reduce costs, and increase efficiency while enabling broader connectivity with partners and services. Founded in 2017 and based in Berlin, Germany.
Loam Bio is a company focused on manufacturing microbial products designed to reduce atmospheric CO2 levels and enhance soil fertility. Founded in 2016 and based in Orange, Australia, the company is engaged in developing innovative technology that enables the inoculation of crops with symbiotic micro-organisms. This approach aims to improve agricultural sustainability by promoting healthier soils and more efficient carbon management.
Q-CTRL develops software tools and firmware for quantum computing to reduce and control quantum bit errors in quantum hardware. Its quantum control infrastructure software supports research and development professionals and end users, accelerating the pathway to the first useful quantum computers and underpinning software-defined quantum sensors for defence, intelligence, navigation, and earth observation. The company collaborates with universities, national labs, and industry partners to advance hardware error management and stability in quantum systems.
Asimov designs and develops biologics and gene therapies, focusing on mammalian cell engineering and genetic circuit design. The company combines synthetic biology, computer-aided design, and machine learning to accelerate the design and manufacture of biologics, viral vectors, and cell and gene therapies. Its platform integrates biophysical simulations with data-driven models of biology to engineer genetic circuits and optimize production processes. Founded in 2017 and based in Cambridge, Massachusetts, Asimov supports healthcare firms in advancing therapeutic pipelines through software and engineering tooling that bridges biology and computational design.
Syzygy Plasmonics
Series C in 2022
Syzygy Plasmonics, Inc. is a Houston-based company that specializes in the design, development, and manufacturing of photocatalytic reactor systems for industrial chemical reactions. Founded in 2017, the company focuses on creating reactors that facilitate the generation of fuel cell quality hydrogen from ammonia, specifically for small-to-medium-scale applications. These advanced reactors operate at significantly lower temperatures than traditional chemical reactors, allowing for reduced maintenance costs and the ability to quickly start or stop production. By utilizing light as an energy source, Syzygy Plasmonics enables the integration of renewable electricity into chemical manufacturing, contributing to the decarbonization of various industries and supporting the on-site production of ultra-low-cost hydrogen gas for fuel cell vehicles.
Detect they build tools that empower people to understand their health.
Juvena Therapeutics
Series A in 2022
Juvena Therapeutics is a biopharmaceutical company developing protein-based therapies to promote tissue rejuvenation and repair in elderly individuals. Founded in 2017, the company focuses on treating age-related conditions such as sarcopenia, wound healing, and neural regeneration.
Nourish Ingredients
Series A in 2022
Nourish Ingredients is a food technology company based in Canberra, Australia, that specializes in creating fat molecules identical to those found in animals, using innovative precision fermentation techniques. Founded in 2019, the company developed proprietary strains that can mass-produce these fat molecules, allowing for the production of plant-based foods that closely mimic the flavor, aroma, and cooking experience associated with animal fats. By providing alternatives to traditional animal-based ingredients, Nourish Ingredients aims to enhance the quality of plant-based products, making them more appealing to consumers seeking authentic taste without the environmental and ethical concerns related to animal agriculture.
Kneron is a designer and developer of integrated software and hardware edge AI solutions, offering AI System-on-Chips, neural processing units, and on-device visual recognition software. The company enables real-time recognition, inference, and analysis on devices without cloud connectivity, supporting smart homes, smart surveillance, smartphones, wearables, robots, drones, and IoT devices. Its technology enables local AI workloads with low latency for a range of consumer and industrial applications. Founded in 2015, Kneron is headquartered in San Diego, with offices in Taipei, Zhuhai, and Shenzhen.
SaNOtize is a biotechnology company developing a platform technology that releases nitric oxide topically to treat and prevent microbial infections. Its primary focus includes indications such as strep throat, athlete's foot, infected wounds, diabetic foot ulcers, sinusitis, colds, and flu.
Carmot Therapeutics
Series D in 2022
Carmot Therapeutics, Inc. is a clinical-stage biotechnology company based in Berkeley, California, with an additional office in San Francisco. Founded in 2008, it focuses on discovering and developing innovative therapies for patients with metabolic diseases, including obesity and diabetes. Utilizing its proprietary Chemotype Evolution technology, Carmot Therapeutics aims to address the underlying causes of these conditions and accelerate the discovery of effective treatments. The company’s portfolio includes several clinical-stage drug candidates, such as CT-388 and CT-996, which are designed as GLP-1 receptor agonists for the treatment of obesity and type 2 diabetes, and CT-868, intended for type 1 diabetes patients who are overweight or obese. Through these efforts, Carmot Therapeutics seeks to create life-changing therapeutics that improve the health outcomes of individuals affected by metabolic diseases.
Normative.io
Series B in 2022
Normative.io is a software company that specializes in assessing the social and environmental impact of companies by analyzing their purchases. Utilizing artificial intelligence and the world's largest sustainability research database, Normative's platform provides an emission accounting engine that helps organizations calculate their total carbon dioxide emissions. The software also offers visual analytics and generates comprehensive sustainability reports, processing both internal and external data to automate carbon reporting. By making the social and environmental costs of purchases transparent, Normative aims to facilitate progress toward achieving the Sustainable Development Goals and assist businesses in reducing their environmental footprint.
Spiderwort
Series A in 2022
Spiderwort is an innovative company based in Ottawa, Ontario, founded in 2015, focused on developing biomaterials for regenerative medicine. The company specializes in creating cellulose-based biomaterials that serve as living scaffolds, which can be utilized for various medical applications, including spinal cord injury repair and soft tissue regeneration. Spiderwort's products encompass a range of biological and synthetic polymers available in multiple forms, such as powders, gels, membranes, and pastes. Currently in the pre-clinical stage, their novel biomaterials have shown promising results in terms of biocompatibility and the ability to induce angiogenesis, which is the generation of blood vessels within the scaffold. This approach aims to advance the repair and regeneration of tissues within the human body, providing new solutions for challenging medical conditions.
Wefox is a technology company specializing in the insurance sector. It operates a digital platform that connects insurance providers, brokers, businesses, and customers, facilitating access to various insurance solutions. The company focuses on indirect sales, partnering with intermediaries to expand its market reach. Wefox's platform offers services such as policy management, claims settlement, and quotation generation for a range of insurance types, including health, liability, and disability.
Keel.Labs
Series A in 2022
Keel Labs is a biomaterials company that focuses on developing ocean-based materials derived from renewable resources, particularly seaweed. The company aims to address the ecological damage caused by the fashion industry by creating durable and rapidly degradable yarns from kelp. Through its innovative platform, Keel Labs integrates scientific design and waste management into textile production, offering an alternative to conventional textiles for the footwear and apparel industries. This approach not only provides a functional resource but also emphasizes environmental sustainability, allowing for a more responsible and accessible option in material sourcing.
Atomo Coffee
Series A in 2022
Atomo Coffee Inc, founded in 2019 and based in Seattle, Washington, specializes in the development of molecular coffee. The company has innovatively reverse-engineered the coffee bean to produce a smooth cup of coffee using naturally derived ingredients. This approach aims to offer a more sustainable alternative to traditional coffee production methods, addressing environmental concerns associated with coffee cultivation. By focusing on sustainability and quality, Atomo Coffee is positioned to disrupt the conventional coffee market with its unique product offerings.
Manifold Bio
Series A in 2022
Manifold Biotechnologies, Inc. is a biotechnology company that specializes in developing platforms for the pharmacological measurement of various therapeutic protein variants. By integrating DNA technologies with machine learning, the company aims to create protein drugs that address challenging diseases. Manifold Bio's innovative approach includes a protein barcoding platform designed to enable multiplexed quantitation of protein therapeutics, thereby generating extensive data that enhances the drug development process. Founded in 2019 and located in Allston, Massachusetts, the company is focused on advancing measurement-driven design in the field of protein therapeutics.
Getquin is a financial technology company that offers a comprehensive platform for investors to manage and track their entire net worth in one location. The platform is designed to facilitate the creation and management of exchange-traded fund portfolios, allowing users to analyze their assets and make informed investment decisions. By providing tools to monitor investments continuously, Getquin fosters a community of like-minded investors, enhancing the decision-making process through shared insights and information. This integrated approach aims to empower individuals to take control of their financial futures.
Voyage Foods
Series A in 2022
Voyage Foods develops sustainable alternatives to popular foods. Using natural ingredients and proprietary technology, they create products like nut-free spreads, cocoa-free chocolate, and bean-free coffee that maintain original taste and nutrition without environmental compromise.
Kelonia Therapeutics
Series A in 2022
Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform. The company's cutting-edge in vivo gene delivery technology is simple and elegant, relying on a few potent lentiviral vector-like particles to precisely and efficiently deliver genetic cargo to the desired target tissue, and only that tissue, every time. To deliver genetic cargo only to the desired tissue, the lentiviral vector gene delivery platform employs a simple and elegant solution based on decades of research, development, and technical experience. Kelonia's mission is to develop a new wave of accessible genetic medicines that will transform the lives of patients suffering from a broad range of conditions.
Ansa Biotechnologies
Series A in 2022
Ansa Biotechnologies, Inc. is a biotechnology company based in Berkeley, California, focused on developing innovative DNA synthesis technology utilizing enzymes. Founded in 2018, the company aims to transform the traditional methods of DNA production, which have remained largely unchanged for decades. Ansa's enzymatic approach promises to be faster, more accurate, and environmentally friendly compared to conventional chemical methods. This advanced technology facilitates the synthesis of gene-length oligonucleotides, enabling medical researchers to create synthetic genes efficiently. Ansa Biotechnologies' offerings are designed to support a wide range of applications in biological research, diagnostics, therapeutics, and biomanufacturing, ultimately accelerating innovation in the field of biotechnology.
Micro Connect
Series B in 2022
Micro Connect is a market platform and infrastructure provider that links global capital with micro and small businesses in China. It develops fintech capabilities and platform infrastructure to enable liquidity in small business investing for professional investors. By offering direct exposure to the daily cash flows of millions of stores in China’s consumer economy through Daily Revenue Obligations, Micro Connect enables accessible and diversified investment opportunities while supporting business owners with affordable capital. The company also operates an ecosystem that includes a fund platform, structured product solutions, and a licensed exchange to support diverse investment approaches and transparent cash-flow investment options.
Concerto Biosciences
Venture Round in 2022
Concerto Biosciences develops microbe-based products that rebuild microbial communities in and around humans and ecosystems. The company uses an ultra-high-throughput platform to experimentally measure millions of microbial interactions and map interaction networks, enabling the discovery of ensembles, which are specific combinations of microbes that work together to shepherd damaged microbial communities back to health. These ensembles have potential applications across medicine and agriculture, addressing global challenges in health, food, and industry. By focusing on microbial community engineering, Concerto aims to become a leading inventor of ensembles and to redefine how microbiomes are leveraged for health and environmental outcomes.
Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in single-cell analysis technology. Founded in 2015, the company has developed an AI-powered imaging and microfluidics platform that offers a non-invasive method for genetic testing with diagnostic-level accuracy. This platform enables researchers to classify and isolate viable cells based on their morphological characteristics, thus facilitating improved diagnosis and treatment of diseases. By providing detailed genetic health information through ordinary blood samples, Deepcell aims to enhance translational research, diagnostic testing, and therapeutic applications, ultimately reducing the need for invasive procedures in medical diagnostics.
Soul Machines
Series B in 2022
Founded in 2016, Soul Machines specializes in developing emotionally responsive digital humans for AI platforms. Its products include Digital DNA Studio, enabling users to create custom avatars for various purposes such as customer care and marketing. Headquartered in Auckland, New Zealand, the company operates globally with offices across North America, Europe, Japan, and Australia.
Founded in 2019, H2Pro develops innovative water-splitting technology for producing hydrogen fuel. Its proprietary E-TAC method decouples hydrogen and oxygen evolution reactions, enabling efficient and sustainable green hydrogen production.
Fertilis
Seed Round in 2022
Fertilis specializes in advanced IVF technology designed to automate and optimize cell culture processes. Their innovative micromedical devices aim to enhance embryo growth conditions, making IVF procedures more successful and less stressful for patients.
MeMed
Venture Round in 2022
MeMed Diagnostics Ltd. is a personalized diagnostics company founded in 2009 and headquartered in Tirat Carmel, Israel. The company specializes in developing innovative diagnostic solutions to enhance patient care and reduce healthcare costs by providing rapid and actionable insights for infectious diseases. Its flagship product, MeMed BV, is a test designed to distinguish between bacterial and viral infections, while the ImmunoDx platform utilizes proprietary biomarkers and algorithms to analyze patients' immune responses, helping physicians make informed antibiotic treatment decisions. MeMed's technologies aim to mitigate the misuse of antibiotics, which is a significant issue globally, leading to ineffective treatments and the emergence of resistant bacterial strains. By addressing the diagnostic gaps in infectious disease management, MeMed seeks to improve clinical outcomes and promote the responsible use of antibiotics.
Eikon Therapeutics
Series B in 2022
Eikon Therapeutics is a biopharmaceutical company that uses proprietary live-cell imaging platforms to discover and develop therapeutics for chronic and life-threatening diseases. Founded in 2019 and based in Hayward, California, the company applies super-resolution, single-molecule, and real-time molecular-resolution observations to study how compounds interact with individual proteins in living cells. By integrating biology, engineering, and chemistry, Eikon seeks to identify previously intractable targets, accelerate the drug-discovery process, and expand its clinical pipeline through platforms that reveal target biology and compound-protein interactions in their native cellular context.
Kopi Kenangan
Series C in 2021
Established in 2017, Kopi Kenangan operates as a grab-and-go coffee chain in Indonesia. It aims to tap into the growing demand for specialty coffee beverages in a market that is one of the world's largest coffee exporters but has relatively low consumption per capita.
Founded in 2017, ZeroAvia develops zero-emission aircraft propulsion systems designed to eliminate aviation emissions while maintaining operational efficiency. The company focuses on scalable hydrogen-electric technologies that can retrofit existing aircraft and support sustainable aviation.
Wonder Dynamics
Series A in 2021
Wonder Dynamics is a media-tech startup based in Los Angeles, California, co-founded by Tye Sheridan and Nikola Todorovic. The company specializes in developing AI technology to enhance storytelling, particularly focusing on creating an AI production tool that enables independent filmmakers to achieve high-quality visual effects typically associated with big-budget productions at a significantly lower cost. Their technology also allows viewers to engage in AI-powered conversations with characters in TV shows or movies, thereby enhancing the viewing experience.
Notpla develops sustainable packaging solutions derived from seaweed and plants. Its product range includes a coating for takeaway boxes, flexible films, paper made from seaweed pulp, and rigid plastic alternatives, all designed to be biodegradable and reduce plastic waste.
Harrison.ai
Series B in 2021
Harrison.ai is a healthcare-focused AI company founded in 2018. Headquartered in Barongarook, Victoria, Australia, it uses deep learning to enhance IVF success rates and improve patient outcomes. The company empowers clinicians with customized AI tools that integrate into existing workflows.
Q-CTRL develops software tools and firmware for quantum computing to reduce and control quantum bit errors in quantum hardware. Its quantum control infrastructure software supports research and development professionals and end users, accelerating the pathway to the first useful quantum computers and underpinning software-defined quantum sensors for defence, intelligence, navigation, and earth observation. The company collaborates with universities, national labs, and industry partners to advance hardware error management and stability in quantum systems.
Synthace is a software company that develops tools for life sciences R&D, enabling automation, digitization, and optimization of biological experiments across health, pharmaceutical, food, energy, and industrial biotechnology sectors. Its cloud-based Antha platform lets users visually design, execute, and analyze biological workflows and automates processes to improve success rates. The platform digitizes experiments end to end, allowing researchers to plan reproducible experiments, simulate them, run them on automation equipment, and automatically structure data and metadata in a centralized workspace. It enables codeless reprogramming of liquid handling and supports multifactorial experimentation by connecting experimental data with other digital tools in the ecosystem. The software is browser-based, requires no coding, and aims to streamline lab workflows, improve data quality, and broaden the scope of experiments that can be conducted. The company operates globally from its base in London, with additional presence in the United States.
Fleet Space Technologies
Series B in 2021
Fleet Space Technologies operates a constellation of commercial micro-satellites, offering enhanced mineral exploration services globally. They have pioneered the world's first 3D printed all-metal patch antenna for space, significantly improving throughput efficiency.
Seasoned.co
Series A in 2021
Seasoned, LLC operates a professional networking platform specifically designed for foodservice industry professionals, including cooks, dishwashers, servers, and gig workers. Based in San Francisco with an additional office in Austin, the company connects workers with job opportunities and fosters career development. Seasoned offers resources such as video courses and articles to help individuals enhance their skills and succeed in their careers. The platform also facilitates networking among foodservice workers, allowing them to share tools, build teams, and improve retention and customer experiences. Founded by a team with extensive experience in the restaurant sector, Seasoned addresses the unique challenges faced by foodservice professionals while promoting growth and collaboration within the industry.
Loam Bio is a company focused on manufacturing microbial products designed to reduce atmospheric CO2 levels and enhance soil fertility. Founded in 2016 and based in Orange, Australia, the company is engaged in developing innovative technology that enables the inoculation of crops with symbiotic micro-organisms. This approach aims to improve agricultural sustainability by promoting healthier soils and more efficient carbon management.
Ansa Biotechnologies
Funding Round in 2021
Ansa Biotechnologies, Inc. is a biotechnology company based in Berkeley, California, focused on developing innovative DNA synthesis technology utilizing enzymes. Founded in 2018, the company aims to transform the traditional methods of DNA production, which have remained largely unchanged for decades. Ansa's enzymatic approach promises to be faster, more accurate, and environmentally friendly compared to conventional chemical methods. This advanced technology facilitates the synthesis of gene-length oligonucleotides, enabling medical researchers to create synthetic genes efficiently. Ansa Biotechnologies' offerings are designed to support a wide range of applications in biological research, diagnostics, therapeutics, and biomanufacturing, ultimately accelerating innovation in the field of biotechnology.
Ajaib is a financial technology company in Indonesia that operates an online investment platform enabling individuals to save and invest by buying and selling stocks, exchange-traded funds, and mutual funds. The company aims to democratize access to financial products by offering low minimums and no account fees, making investing affordable for a broad base of retail investors. Headquartered in Jakarta, Ajaib provides a digital-first solution that simplifies investing and financial planning for Indonesian users.
Perfect Day
Series D in 2021
Perfect Day develops animal-free dairy proteins and dairy substitutes using fermentation to produce proteins that are nutritionally identical to cow’s milk. The company makes products including milk, cheese, yogurt, ice cream, and milk proteins without using animals. Its fermentation process uses yeast to convert plant-based sugars into dairy proteins, enabling products with the same taste, texture, and nutrition as traditional dairy while avoiding animal welfare concerns and reducing environmental impact. Founded in 2014 and headquartered in Emeryville, California, Perfect Day focuses on sustainable, vegan dairy alternatives that aim to appeal to both consumers and manufacturers seeking dairy-like ingredients without conventional dairy farming.
Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.
Prospection
Series B in 2021
Prospection Pty Ltd, established in 2009, is a Sydney-based software company specializing in healthcare data analytics. It develops SaaS platforms that transform complex healthcare data into actionable insights. Key products include PharmDash, which analyzes patient drug usage and treatment progression, and PharmMap, which integrates commercial and operational data using geospatial mapping. Prospection serves pharmaceutical companies, research institutions, and hospitals worldwide, aiding them in optimizing drug performance and enhancing patient outcomes.
Owlstone Medical
Series D in 2021
Owlstone Medical develops and commercializes breathalyzers for clinical diagnostics and precision medicine. Its products detect volatile organic compounds in breath samples to diagnose diseases like lung cancer, asthma, and tuberculosis. The company has strategic collaborations with pharmaceutical companies and is based in Cambridge, UK.
Alpaca is an embedded financial technologies platform that provides real-time market data, crypto and stock investing, and end-to-end brokerage infrastructure via modern APIs. It serves hundreds of global applications and businesses, with tens of thousands of active developers.
V2food is a plant-based meat startup founded in 2019 by Nick Hazell and located in Sydney, New South Wales, Australia. The company specializes in producing legume-based meat alternatives that provide a nutritious and flavorful option for individuals who enjoy the taste of meat but prefer not to consume animal products. V2food's offerings are designed to be sustainable and eco-friendly, utilizing natural ingredients that deliver essential protein, energy, fiber, and specific amino acids. By focusing on reducing greenhouse gas emissions, land degradation, and biodiversity loss, V2food aims to foster a positive relationship with food while contributing to a more sustainable food system.
ZeroAvia
Venture Round in 2021
Founded in 2017, ZeroAvia develops zero-emission aircraft propulsion systems designed to eliminate aviation emissions while maintaining operational efficiency. The company focuses on scalable hydrogen-electric technologies that can retrofit existing aircraft and support sustainable aviation.
Bad Robot Games
Series B in 2021
Bad Robot Games, founded by filmmaker J.J. Abrams, focuses on storytelling and world-building through the medium of games. The company leverages the expertise of industry veterans from both the gaming and entertainment sectors, creating immersive experiences that blend interactive gameplay with cinematic narratives. Bad Robot Games aims to unite diverse artistic perspectives to develop expansive worlds that engage audiences across various platforms, including gaming, animation, and motion films. With a commitment to innovation and creativity, the company aspires to deliver experiences that are enjoyable to both play and watch. Based in Santa Monica, Bad Robot Games is part of the broader Bad Robot brand, known for its successful television and film projects.
Modern Meadow
Series C in 2021
Founded in 2011, Modern Meadow is a biofabrication company based in Brooklyn, New York. It specializes in growing animal-free leather using living cells, aiming to provide sustainable alternatives without compromising performance.
Syzygy Plasmonics
Series B in 2021
Syzygy Plasmonics, Inc. is a Houston-based company that specializes in the design, development, and manufacturing of photocatalytic reactor systems for industrial chemical reactions. Founded in 2017, the company focuses on creating reactors that facilitate the generation of fuel cell quality hydrogen from ammonia, specifically for small-to-medium-scale applications. These advanced reactors operate at significantly lower temperatures than traditional chemical reactors, allowing for reduced maintenance costs and the ability to quickly start or stop production. By utilizing light as an energy source, Syzygy Plasmonics enables the integration of renewable electricity into chemical manufacturing, contributing to the decarbonization of various industries and supporting the on-site production of ultra-low-cost hydrogen gas for fuel cell vehicles.
Founded in 2017, ZeroAvia develops zero-emission aircraft propulsion systems designed to eliminate aviation emissions while maintaining operational efficiency. The company focuses on scalable hydrogen-electric technologies that can retrofit existing aircraft and support sustainable aviation.
Ajaib is a financial technology company in Indonesia that operates an online investment platform enabling individuals to save and invest by buying and selling stocks, exchange-traded funds, and mutual funds. The company aims to democratize access to financial products by offering low minimums and no account fees, making investing affordable for a broad base of retail investors. Headquartered in Jakarta, Ajaib provides a digital-first solution that simplifies investing and financial planning for Indonesian users.
Nourish Ingredients
Seed Round in 2021
Nourish Ingredients is a food technology company based in Canberra, Australia, that specializes in creating fat molecules identical to those found in animals, using innovative precision fermentation techniques. Founded in 2019, the company developed proprietary strains that can mass-produce these fat molecules, allowing for the production of plant-based foods that closely mimic the flavor, aroma, and cooking experience associated with animal fats. By providing alternatives to traditional animal-based ingredients, Nourish Ingredients aims to enhance the quality of plant-based products, making them more appealing to consumers seeking authentic taste without the environmental and ethical concerns related to animal agriculture.
Keel.Labs
Venture Round in 2021
Keel Labs is a biomaterials company that focuses on developing ocean-based materials derived from renewable resources, particularly seaweed. The company aims to address the ecological damage caused by the fashion industry by creating durable and rapidly degradable yarns from kelp. Through its innovative platform, Keel Labs integrates scientific design and waste management into textile production, offering an alternative to conventional textiles for the footwear and apparel industries. This approach not only provides a functional resource but also emphasizes environmental sustainability, allowing for a more responsible and accessible option in material sourcing.
Voyage Foods
Seed Round in 2021
Voyage Foods develops sustainable alternatives to popular foods. Using natural ingredients and proprietary technology, they create products like nut-free spreads, cocoa-free chocolate, and bean-free coffee that maintain original taste and nutrition without environmental compromise.
ALE is a pioneering company founded in 2011 that specializes in creating innovative space entertainment experiences, including the world's first man-made meteor showers. By utilizing microsatellites to release particles that create atmospheric phenomena, ALE aims to merge meteor science with entertainment, stimulating public curiosity about space and science. The company operates with two primary goals: to entertain and inspire people while collecting valuable data from the mesosphere to enhance understanding of atmospheric phenomena and contribute to climate change research. ALE fosters a collaborative community of scientists, decision-makers, and the general public, promoting the exploration of the universe and encouraging a sustainable future on Earth. Through its unique approach, ALE connects scientific knowledge with societal interest, making the cosmos an engaging cultural sphere.
Otter.ai is a company that develops an AI-based application for everyday conversations. Its Otter mobile and web app allows users to store, search, and share voice conversations, managing them like text messages or emails. The platform uses AI-powered speech recognition to transcribe conversations with multiple participants and in challenging acoustic environments. It is used by individuals, teams, and educational users to create collaborative notes from meetings, interviews, and lectures. Otter supports real-time transcripts, speaker identification, keyword extraction, and searchable notes with text, audio, and images; notes can be shared or exported and accessed across devices. The company was founded in 2016 and is headquartered in Los Altos, California.
Kuato
Venture Round in 2021
Kuato Studios is an educational games developer based in London that focuses on enhancing children's learning through engaging video games. The company aims to capture the excitement of learning by blending high production values with innovative educational methodologies. Kuato's team consists of professionals from renowned gaming studios, AI experts, and award-winning educators, fostering a collaborative environment that balances development and educational objectives. Their adaptive learning platform, KAI, personalizes educational experiences, ensuring that each user is motivated and engaged. By prioritizing narrative learning play, Kuato enables young learners to explore and share their stories in a playful manner, setting a new standard for educational games.
Ajaib is a financial technology company in Indonesia that operates an online investment platform enabling individuals to save and invest by buying and selling stocks, exchange-traded funds, and mutual funds. The company aims to democratize access to financial products by offering low minimums and no account fees, making investing affordable for a broad base of retail investors. Headquartered in Jakarta, Ajaib provides a digital-first solution that simplifies investing and financial planning for Indonesian users.
Founded in 2018, Xampla develops plant-based materials derived from pea protein to replace microplastics. Its product range includes microcapsules for homecare and personal care products, films, coatings, and single-use plastics for packaging applications.
Founded in 2017, ZeroAvia develops zero-emission aircraft propulsion systems designed to eliminate aviation emissions while maintaining operational efficiency. The company focuses on scalable hydrogen-electric technologies that can retrofit existing aircraft and support sustainable aviation.
Refeyn Ltd develops and commercializes mass photometry technology for measuring the mass of single biomolecules in solution. The company offers instruments and accessories, including Refeyn One, which uses single-molecule light scattering to detect, image, and determine the mass of biomolecules in their native, unlabeled state. Its technology provides both research-grade tools and quality-control instruments for measuring biomolecules across a range of concentrations, enabling label-free mass measurement of individual molecules. Founded in 2018 and based in Oxford, United Kingdom, Refeyn focuses on delivering precise, rapid mass analysis to researchers studying proteins, nucleic acids, and other biomolecules.
V2food is a plant-based meat startup founded in 2019 by Nick Hazell and located in Sydney, New South Wales, Australia. The company specializes in producing legume-based meat alternatives that provide a nutritious and flavorful option for individuals who enjoy the taste of meat but prefer not to consume animal products. V2food's offerings are designed to be sustainable and eco-friendly, utilizing natural ingredients that deliver essential protein, energy, fiber, and specific amino acids. By focusing on reducing greenhouse gas emissions, land degradation, and biodiversity loss, V2food aims to foster a positive relationship with food while contributing to a more sustainable food system.
Federation Bio
Series A in 2020
Federation Bio Inc., established in 2018 and headquartered in South San Francisco, California, specializes in the development of microbial therapeutics targeting diseases where the human microbiome holds curative potential. The company's platforms focus on secondary hyperoxaluria and explore treatments for metabolic disorders, immune diseases, and cancer. Federation Bio's approach involves leveraging naturally occurring or engineered bacteria alongside a diverse community of supportive bacteria to drive engraftment and durable therapeutic responses.
Carmot Therapeutics
Series C in 2020
Carmot Therapeutics, Inc. is a clinical-stage biotechnology company based in Berkeley, California, with an additional office in San Francisco. Founded in 2008, it focuses on discovering and developing innovative therapies for patients with metabolic diseases, including obesity and diabetes. Utilizing its proprietary Chemotype Evolution technology, Carmot Therapeutics aims to address the underlying causes of these conditions and accelerate the discovery of effective treatments. The company’s portfolio includes several clinical-stage drug candidates, such as CT-388 and CT-996, which are designed as GLP-1 receptor agonists for the treatment of obesity and type 2 diabetes, and CT-868, intended for type 1 diabetes patients who are overweight or obese. Through these efforts, Carmot Therapeutics seeks to create life-changing therapeutics that improve the health outcomes of individuals affected by metabolic diseases.
Brightseed
Venture Round in 2020
Brightseed, Inc. is a pioneering biosciences company based in San Francisco, California, founded in 2017. It specializes in the discovery of bioactive compounds in plants that have beneficial effects on human health, particularly for chronic disease management. Utilizing its proprietary Forager platform, which incorporates artificial intelligence and machine learning, Brightseed accelerates the identification and validation of these naturally occurring compounds, transforming what was once a lengthy process into a matter of months. By mapping bioactives to specific health outcomes, Brightseed provides valuable insights and science-backed solutions to partners across the consumer health continuum. The company's innovative approach aims to illuminate the connections between nature and human health, ultimately improving quality of life and addressing health challenges through the exploration of previously uncharted plant compounds.
Curio is a platform that allows individuals to stay informed by listening to hand-picked human-narrated news and articles from reliable publications, plus original shows and podcasts. Curio allows users to listen to the best articles from The Atlantic, The Wall Street Journal, The Financial Times, WIRED, The Economist, The Washington Post, Bloomberg, Aeon, and many other publications.
Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.
Atomo Coffee
Seed Round in 2020
Atomo Coffee Inc, founded in 2019 and based in Seattle, Washington, specializes in the development of molecular coffee. The company has innovatively reverse-engineered the coffee bean to produce a smooth cup of coffee using naturally derived ingredients. This approach aims to offer a more sustainable alternative to traditional coffee production methods, addressing environmental concerns associated with coffee cultivation. By focusing on sustainability and quality, Atomo Coffee is positioned to disrupt the conventional coffee market with its unique product offerings.
Docket, Inc. is a company that offers an online platform specifically designed for creating meeting agendas. Founded in 2018 and headquartered in Indianapolis, Indiana, Docket provides a workspace that facilitates collaborative agenda development, documentation of decisions, and tracking of action items. This platform aims to enhance the efficiency and organization of meetings, ensuring that users can effectively manage their discussions and follow-ups.
Perfect Day
Series C in 2020
Perfect Day develops animal-free dairy proteins and dairy substitutes using fermentation to produce proteins that are nutritionally identical to cow’s milk. The company makes products including milk, cheese, yogurt, ice cream, and milk proteins without using animals. Its fermentation process uses yeast to convert plant-based sugars into dairy proteins, enabling products with the same taste, texture, and nutrition as traditional dairy while avoiding animal welfare concerns and reducing environmental impact. Founded in 2014 and headquartered in Emeryville, California, Perfect Day focuses on sustainable, vegan dairy alternatives that aim to appeal to both consumers and manufacturers seeking dairy-like ingredients without conventional dairy farming.
Ansa Biotechnologies
Seed Round in 2020
Ansa Biotechnologies, Inc. is a biotechnology company based in Berkeley, California, focused on developing innovative DNA synthesis technology utilizing enzymes. Founded in 2018, the company aims to transform the traditional methods of DNA production, which have remained largely unchanged for decades. Ansa's enzymatic approach promises to be faster, more accurate, and environmentally friendly compared to conventional chemical methods. This advanced technology facilitates the synthesis of gene-length oligonucleotides, enabling medical researchers to create synthetic genes efficiently. Ansa Biotechnologies' offerings are designed to support a wide range of applications in biological research, diagnostics, therapeutics, and biomanufacturing, ultimately accelerating innovation in the field of biotechnology.
Loam Bio
Seed Round in 2020
Loam Bio is a company focused on manufacturing microbial products designed to reduce atmospheric CO2 levels and enhance soil fertility. Founded in 2016 and based in Orange, Australia, the company is engaged in developing innovative technology that enables the inoculation of crops with symbiotic micro-organisms. This approach aims to improve agricultural sustainability by promoting healthier soils and more efficient carbon management.
Surrozen, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, focused on developing targeted regenerative antibodies to enhance tissue and organ repair in response to serious diseases. Founded in 2015, the company specializes in modulating the Wnt pathway, a crucial mediator of tissue regeneration, through its innovative antibody platforms that target specific organs and tissues. Notable programs include SZN-043, designed to stimulate liver regeneration in both acute and chronic liver diseases, and SZN-1326, aimed at repairing damaged epithelial tissue in patients with inflammatory bowel disease. Surrozen's approach extends to multiple organ systems, with potential applications in the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.